These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7801627)

  • 1. Alzheimer's disease: a new hope.
    Hasan MK; Mooney D
    W V Med J; 1994 Oct; 90(10):418-9. PubMed ID: 7801627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: it's irreversible but not untreatable.
    Filley CM
    Geriatrics; 1995 Jul; 50(7):18-23. PubMed ID: 7601358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helping Alzheimer's research.
    Hosp Pract (1995); 1996 Oct; 31(10):40, 42. PubMed ID: 8859204
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT; Guardado-Santervás P
    Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoprotein E4: phenotype in patients with Alzheimer's disease.
    Mahieux F; Couderc R; Moulignier A; Bailleul S; Podrabinek N; Laudet J
    Ann Neurol; 1994 Apr; 35(4):506-7. PubMed ID: 8154882
    [No Abstract]   [Full Text] [Related]  

  • 6. Alzheimer's and Cognex.
    Steel JG
    N C Med J; 1995 Feb; 56(2):72-3. PubMed ID: 7741935
    [No Abstract]   [Full Text] [Related]  

  • 7. [Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease].
    Estadieu MC; Machou C; Berthezène P; Pastor MJ; Angelini B; Bohor M; Bongrand MC; Timon-David P; Gastaut JL; Allain H; Michel BF
    Therapie; 1998; 53(1):67-76. PubMed ID: 9773102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tacrine in Alzheimer's disease].
    López de Munain A
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract]   [Full Text] [Related]  

  • 10. [The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset].
    Kurz A; Lautenschlager N; Haupt M; Zimmer R; von Thülen B; Altland K; Lauter H; Müller U
    Nervenarzt; 1994 Nov; 65(11):774-9. PubMed ID: 7816154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tacrine in the treatment of Alzheimer's disease].
    Weinstein HC; Teunisse S; van Gool WA; van Crevel H
    Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487
    [No Abstract]   [Full Text] [Related]  

  • 12. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
    Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.
    Gutzmann H; Kühl KP; Hadler D; Rapp MA
    Pharmacopsychiatry; 2002 Jan; 35(1):12-8. PubMed ID: 11819153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE: new risk factor for Alzheimer's.
    Butler RN
    Geriatrics; 1994 Aug; 49(8):10-1. PubMed ID: 8039724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments for Alzheimer's disease.
    Harvey R; Rossor M
    Practitioner; 1995 Jul; 239(1552):440-3. PubMed ID: 7659667
    [No Abstract]   [Full Text] [Related]  

  • 19. Alzheimer's disease: new horizons in diagnosis and treatment.
    Rankin L
    Iowa Med; 1997; 87(5):199-201. PubMed ID: 9149495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE-epsilon 4 and early-onset Alzheimer's.
    Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
    Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.